Keyword: Fujifilm Diosynth Biotechnologies


Fujifilm Invests $1.6 Billion for Cell Culture Expansion

14.07.2022 -

Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...


Fujifilm Selects US Cell Site, Inks Biotech Deals

23.03.2021 -

Fujifilm Diosynth Biotechnologies has chosen Holly Springs in North Carolina as the site of its new large-cell culture production site in the US. The company first...


Fujifilm Diosynth Biotechnologies, Piramal Announce Strategic Alliance

24.10.2012 - Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract...


Fujifilm Diosynth Biotechnologies Expands Mammalian Cell Culture cGMP Capabilities

19.06.2012 - Fujifilm Diosynth Biotechnologies has announced it is further increasing its contract process development and manufacturing capabilities through the expansion of its services in...